FDA Inspection 1193221 — R&D Engineering, Inc. of Earlham

R&D Engineering, Inc. of Earlham — FEI 3009418685

The FDA completed an inspection of R&D Engineering, Inc. of Earlham on December 15, 2022 in Earlham, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 15, 2022
Fiscal Year
2023
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Earlham, IA (United States)

Citations

IDCFRDescription
316021 CFR 820.184Lack of or inadequate DHR procedures
320121 CFR 820.40(a)Not approved or obsolete document retrieval